Innovative Healthcare: Agreed to sign relevant agreements such as participating in the B+ round capital increase of the joint stock company.

Innovative Healthcare announced that the 4th extraordinary meeting of the 7th Board of Directors of the company in 2025 was held via communication voting, with all 9 directors attending. The meeting was passed unanimously with 9 votes in favor, 0 votes against, and 0 abstentions, approving the proposal to sign the "B+ round capital increase agreement", "B+ round shareholder agreement" and related documents for the joint venture company, Quan Zhen Medical. The directors agreed to sign the relevant documents for the B+ round capital increase of Quan Zhen Medical, and waive their preemptive rights or similar rights in this financing round.